Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small bubble of air inside a Mounjaro KwikPen is normal and, in almost every case, harmless. The pen is not broken, the medicine is not wasted, and you do not need to prime it like an old-style syringe. The liquid tirzepatide you see in the cartridge simply contains a tiny air pocket — this is expected with pre-filled autoinjector devices and does not affect the dose you receive. That said, a few specific bubble scenarios do need attention, and knowing which is which matters before you inject. These are prescription-only medicines reviewed individually by a prescriber; for anything beyond straightforward technique questions, your clinical team should be your first call. Learn more about how Mounjaro works before reading on.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common concern our prescribers hear about Mounjaro bubbles goes roughly like this: "I was always told to tap a syringe and push the air out before injecting, shouldn't I do the same here?" The answer is no, and the confusion is understandable. That rule applies to manually drawn syringes, not to pre-filled autoinjectors. The tirzepatide KwikPen is factory-filled and factory-set; the dose mechanism is calibrated to deliver the correct volume regardless of a small air space in the cartridge. Trying to expel air by pressing the plunger before capping and injecting would actually waste medicine.
Air entering the subcutaneous tissue (the fatty layer just under the skin where the pen delivers tirzepatide) carries no clinical risk. This is not an intravenous injection. Small air pockets subcutaneously are absorbed without consequence. If you would like a dedicated explanation of why this is the case, our guide to bubbles in Mounjaro covers the topic in full detail. The Mounjaro Patient Information Leaflet (available via the electronic Medicines Compendium) confirms this position, and it is consistent with Eli Lilly's pen instructions worldwide.
So the practical upshot: if you hold the pen up to the light, see a bubble, and everything else looks normal, carry on with your injection as described in the leaflet. Tapping, shaking, or partially pressing the button before you are ready will do more harm than good.
Most bubbles you notice are small, a few millimetres, sometimes moving around as you tilt the pen. Those are fine. The situations worth stopping for are different in character.
First, a bubble so large it takes up a visible proportion of the cartridge window. A pen that looks partly empty when it should be full, or where the liquid level has dropped noticeably since you collected it, could indicate a leak or a damaged cartridge seal. Second, any change in the appearance of the liquid itself: Mounjaro solution should be clear and colourless to slightly yellow. Cloudiness, visible particles, or a colour change are reasons to set that pen aside and contact your pharmacy. Third, if the pen has been dropped hard onto a solid surface, a hairline crack in the cartridge is possible even if it looks intact externally.
In all three cases, do not inject. Contact your supplying pharmacy first. If you are a nume patient, our support team is available seven days a week and can advise you on a replacement if one is warranted.
One practical note on timing: if you ordered over a bank holiday or long weekend and the pen has been sitting at room temperature for longer than you expected, check the leaflet's room-temperature storage window carefully, the permitted duration is stated there, and the specific figure is the SmPC's to give, not ours.
Correct technique reduces the chance of noticing a bubble at the wrong moment and keeps each dose consistent. Remove the pen from the fridge and let it reach room temperature for about 30 minutes, cold liquid can feel more uncomfortable going in and may make the cartridge contents look slightly different. Do not shake the pen. Hold it up briefly to inspect the liquid; if it looks clear and the window shows the expected fill level, attach the needle, choose your injection site (abdomen, thigh, or upper arm, rotated each week) and follow the leaflet steps.
The pen clicks when the dose is complete. Holding it against the skin for a further ten seconds after that click lets the full volume dispense before withdrawal. If you remove the pen before the click or immediately after it, some medicine may be lost, that is a more consequential issue than any air bubble.
For a fuller look at injection sites and rotating them correctly, the guide to injecting Mounjaro in the thigh covers the practical detail. Storage basics are discussed on the Mounjaro dose and pen overview.
If you are repeatedly noticing unusually large bubbles across multiple pens from the same batch, that is worth reporting. The MHRA's Yellow Card scheme exists precisely for suspected product quality issues, anyone can submit a report, not just healthcare professionals. A pattern of defective pens from a particular batch is useful safety data.
Beyond quality concerns, a prescriber's input matters if you are unsure whether your injection went in correctly, or if you notice unusual local reactions at the injection site. Minor redness, itching, or a small lump directly under the skin after an injection are common and usually short-lived. Persistent lumps, bruising that spreads, or signs of infection are not something to wait out.
Mounjaro is a prescription-only medicine, and the clinical relationship with your prescriber does not end at dispensing. If you are considering starting treatment, understanding how UK access works is a good place to begin. When you are ready to see whether it's clinically suitable for you, check your eligibility with our prescribers, no commitment required to start the conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.